Quay lại
Giá HBM Holdings Limited (2142.HK)
Biểu đồ giá cổ phiếu 2142.HK
HBM HOLDINGS-B (2142.HK)
HBM Holdings Limited
HK$14.38
-1.03%
$-0.14
Thị trường đóng cửa: Jan 16, 16:00:00 HKT
Thống kê chính
Giá đóng cửa trước
$14.53
Giá mở cửa
$14.53
Phạm vi ngày
$14.03 - $14.68
Phạm vi 52 tuần
$2.9 - $17.98
Khối lượng
2.8M
Khối lượng trung bình
4.4M
EPS (TTM)
0.73
Tỷ suất cổ tức
--
Vốn hóa thị trường
$12.0B
HBM HOLDINGS-B là gì?
HBM Holdings Ltd. is an investment company, which engages in the discovery and development of differentiated antibody therapeutics in oncology and immunology disease areas. The company is headquartered in Suzhou, Jiangsu and currently employs 210 full-time employees. The company went IPO on 2020-12-10. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The firm provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved